相关实验视频
Updated: May 20, 2025

14:04
Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
17.1K
DLL4/VEGF双特异分子印记纳米导弹用于强大的瘤治疗
Fang Jin1, Peixin Guan1, Lingrui Huang1
1State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing, 210023, China.
Biomaterials
|May 17, 2025
概括
这项研究引入了一种新的双特异性纳米导弹 (bsMINM),它针对VEGF和DLL4来抑制瘤血管生成. 这种双重作用的方法增强了抗瘤效果,克服了耐药性.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 瘤血管生成对于瘤生长和转移至关重要.
- 补偿性血管生成导致药物耐药性和瘤复发.
- 针对像VEGF和DLL4这样的关键血管生成途径对于有效的癌症治疗至关重要.
研究的目的:
- 开发一种双特异的分子印记纳米导弹 (bsMINM),同时抑制VEGF和DLL4.
- 为了增强抗瘤血管生成和克服抵抗机制.
- 在临床前癌症模型中研究bsMINM的疗效.
主要方法:
- 工程的bsMINM与VEGF和DLL4N-表位素的特定结合点.
- 抑制VEGF-VEGFR和DLL4-Notch信号通路的作用.
- 在MCF-7异种移植模型中评估bsMINM疗效.
主要成果:
- bsMINM有效地准并抑制VEGF和DLL4.
- 双阻塞显著增强抗瘤血管生成和瘤生长抑制.
- 在体内,bsMINM在抑制瘤进展和减少癌细胞自我更新方面表现出有效性.
结论:
- 该bsMINM代表了增强抗血管生成疗法的新策略.
- 通过bsMINM同时准VEGF和DLL4,可以克服信号通路补偿.
- 这个平台显示了改善癌症治疗结果的重大前景.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450

